IACS-10759 Hydrochloride is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective inhibitor of oxidative phosphorylation (OXPHOS) in cancer cells, targeting their metabolic pathways. This compound is particularly effective in treating tumors that rely heavily on OXPHOS for energy production, such as certain types of acute myeloid leukemia (AML) and solid tumors. By disrupting the energy metabolism of cancer cells, it induces cell death while sparing normal cells, making it a promising candidate for targeted cancer therapy. Current research focuses on its efficacy in preclinical models and its potential use in combination with other anticancer agents to enhance treatment outcomes.